Skip to content

Preliminary validation of qNoX index for intraoperative nociception and analgesia

Preliminary validation of qNoX index for intraoperative nociception and analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046063
Enrollment
Unknown
Registered
2021-05-03
Start date
2021-05-17
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative nociception

Interventions

Group 1:Remifentanil 2 ng/ml
Group 2:Remifentanil 4 ng/ml

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Preparing for elective surgery undergoing general anesthesia; 3. Patients who need arterial catheterization to monitor invasive arterial pressure during surgery.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment; 2. Pregnant or lactating; 3. Mental illness or nervous system disease; 4. Abuse of alcohol or illegal drugs; 5. Serious arrhythmia.

Design outcomes

Primary

MeasureTime frame
Evaluated the abilities of the qNOX index to discriminate between noxious and nonnoxious stimuli;

Secondary

MeasureTime frame
Evaluated the abilities of the qNOX index to progressively respond to graded stimuli;Evaluated the abilities of the qNOX index to respond to opioid administration.;Evaluated the abilities of the qNOX index to discriminate different levels of analgesia;

Countries

China

Contacts

Public ContactKong Hao

Peking University First Hospital

konghao2438@126.com+86 10 83575138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026